Behçet Disease: Clinical Trials

2 trials for Behçet Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow Behçet Disease: new trials by email Literature Review of Behçet Disease trials Research Report on Behçet Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Apremilast, Placebo - Behçet Disease
Phase 3RecruitingAmgen602021-09-092026-07-24
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
Interferon Alfa-2A, Cyclosporine Pill - Behçet Disease, Uveitis
Phase 3CompletedPeking Union Medical College Hospital282017-06-302021-02-23

Narrower conditions

Behcet Syndrome (2)  ·  Oral Ulcer (1)  ·  Uveitis (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Eye Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hereditary Autoinflammatory Diseases (2)  ·  Mouth Diseases (2)  ·  Panuveitis (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin Diseases, Vascular (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Stomatognathic Diseases (2)  ·  Uveal Diseases (2)  ·  Uveitis, Anterior (2)  ·  Vascular Diseases (2)

Interventions

Cyclosporine (1)  ·  Interferon alpha-2 (1)  ·  apremilast (1)

Sponsors

Amgen (1)  ·  Peking Union Medical College Hospital (1)

Countries

China (1)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

NIH funding

2023 (1)